Essential Partners’s Zura Bio ZURA Stock Holding History

Essential Partners’s Portfolio ZURA Stock Details ZURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-292	Closed	-$1.26K	–	2939
2025 Q3	$1.26K	Sell	292 -218	-43%	-$392	﹤0.01%	1950
2025 Q2	$536	Buy	+510	New	+$610	﹤0.01%	1683

Other funds holding ZURA

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Pfizer New York $170M AUM 191.09% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Essential Partners's ZURA Position: Q4 2025 in Review

Essential Partners sold out of Zura Bio (ZURA) in Q4 2025, closing a stake of 292 shares — an estimated $1.26K sold.

Essential Partners first reported a position in ZURA in Q2 2025 and held it in 2 quarters. The position peaked at $1.26K in Q3 2025. 75 funds tracked by Wall St. Rank hold ZURA as of Q4 2025.

Essential Partners reported no remaining Zura Bio position as of Q4 2025 after selling out during the quarter.
Essential Partners sold 292 Zura Bio shares in Q4 2025, an estimated $1.26K.
Essential Partners first reported a position in Zura Bio in Q2 2025 and held it in 2 quarters.
Essential Partners's Zura Bio position peaked at $1.26K in Q3 2025.
75 funds tracked by Wall St. Rank held Zura Bio as of Q4 2025.

Based on Essential Partners's 13F filing for Q4 2025, filed 21 May 2026.